New Advances in Dyslipidemias

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

New Advances in Dyslipidemias

By University of Louisville FEATURING Dinesh Kalra

1,022 views

January 5, 2023

Dinesh K. Kalra, M.D., FACC, FSCCT, FSCMR, FNLA, Professor of Medicine and Radiology; Chief, Division ...
read more ↘ of Cardiovascular Medicine; Endowed Chair in Cardiovascular Innovations; Vice Chair for Quality; and Director, Advanced Cardiac Imaging, Lipid Clinic, and Infiltrative Cardiac Disease Program at the University of Louisville School of Medicine, focused on appreciating the latest developments regarding the role of lipoproteins in cardiovascular risk prediction (e.g., TRLs, HDL-C, Lp(a)), discussing the use of newer agents for treating dyslipidemias (e.g., bempedoic acid, PCSK9i, evinacumab, etc.), and implementing new LDL-C targets in your practice by identifying patents for secondary versus primary prevention.
↖ read less

Comments 1